ALKEM.NSALKEM.NSNSE
Loading
EBITDA Over TimeStrong
Percentile Rank100
3Y CAGR+23.9%
5Y CAGR+8.5%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+23.9%/yr
vs +9.6%/yr prior
5Y CAGR
+8.5%/yr
Recent acceleration
Acceleration
+14.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$32.78B+9.1%
2025$30.06B+24.2%
2024$24.20B+40.5%
2023$17.23B-21.4%
2022$21.91B+0.7%
2021$21.76B+38.9%
2020$15.67B+31.1%
2019$11.95B+6.8%
2018$11.19B+1.2%
2017$11.06B-